Marina Noris
#155,022
Most Influential Person Now
Researcher ORCID ID = 0000-0001-7651-5033
Marina Noris's AcademicInfluence.com Rankings
Marina Noriscomputer-science Degrees
Computer Science
#8465
World Rank
#8898
Historical Rank
Computational Linguistics
#1889
World Rank
#1909
Historical Rank
Machine Learning
#3472
World Rank
#3515
Historical Rank
Artificial Intelligence
#3773
World Rank
#3828
Historical Rank
Download Badge
Computer Science
Marina Noris's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Marina Noris Influential?
(Suggest an Edit or Addition)Marina Noris's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Natural versus adaptive regulatory T cells. (2005) (1080)
- Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. (2010) (880)
- Atypical hemolytic-uremic syndrome. (2009) (720)
- Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. (2006) (711)
- Overview of Complement Activation and Regulation (2013) (571)
- Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. (1995) (559)
- Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. (2001) (487)
- Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. (2017) (429)
- Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells1 (2008) (429)
- Thrombomodulin mutations in atypical hemolytic-uremic syndrome. (2009) (420)
- Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. (2003) (379)
- STEC-HUS, atypical HUS and TTP are all diseases of complement activation (2012) (353)
- Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. (2003) (343)
- Mechanisms of Disease: pre-eclampsia (2005) (329)
- The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. (2001) (323)
- Familial haemolytic uraemic syndrome and an MCP mutation (2003) (320)
- Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. (2013) (320)
- Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. (2011) (278)
- The case of complement activation in COVID-19 multiorgan impact (2020) (264)
- Dynamics of complement activation in aHUS and how to monitor eculizumab therapy. (2014) (263)
- Factor H family proteins: on complement, microbes and human diseases. (2001) (263)
- [Hemolytic uremic syndrome]. (2005) (248)
- Regulatory T cells and T cell depletion: role of immunosuppressive drugs. (2007) (246)
- Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. (1993) (238)
- Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. (2005) (236)
- Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis (2011) (235)
- MYO1E mutations and childhood familial focal segmental glomerulosclerosis. (2011) (229)
- Atypical aHUS: State of the art. (2015) (226)
- Thrombotic Microangiopathy After Kidney Transplantation (2010) (223)
- Complement and the atypical hemolytic uremic syndrome in children (2008) (222)
- Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? (1999) (221)
- von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. (2002) (192)
- Uremic bleeding: closing the circle after 30 years of controversies? (1999) (190)
- The interactive Factor H–atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models (2007) (180)
- Renal and systemic nitric oxide synthesis in rats with renal mass reduction. (1997) (177)
- Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura. (1999) (166)
- C3 glomerulopathy — understanding a rare complement-driven renal disease (2019) (161)
- l-Arginine Depletion in Preeclampsia Orients Nitric Oxide Synthase Toward Oxidant Species (2004) (160)
- Combined kidney and liver transplantation for familial haemolytic uraemic syndrome (2002) (158)
- Localization of Mesenchymal Stromal Cells Dictates Their Immune or Proinflammatory Effects in Kidney Transplantation (2012) (157)
- Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation (2013) (154)
- Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. (2007) (150)
- Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome. (2007) (144)
- Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion. (2005) (143)
- Eculizumab in a patient with dense-deposit disease. (2012) (140)
- Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. (1995) (139)
- Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement. (2005) (138)
- Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. (2005) (138)
- Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome. (2007) (130)
- Hemolytic Uremic Syndrome: A Fatal Outcome after Kidney and Liver Transplantation Performed to Correct Factor H Gene Mutation (2005) (129)
- Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015 (2015) (129)
- Hemolytic Uremic Syndrome in Pregnancy and Postpartum. (2017) (120)
- Mutations in FN1 cause glomerulopathy with fibronectin deposits (2008) (113)
- Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome. (2016) (112)
- Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy (2018) (110)
- Sirolimus Versus Cyclosporine Therapy Increases Circulating Regulatory T Cells, But Does Not Protect Renal Transplant Patients Given Alemtuzumab Induction From Chronic Allograft Injury (2007) (108)
- Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura. (2012) (108)
- Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function (2017) (103)
- Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome. (2015) (103)
- Pathogenesis of Takayasu's arteritis. (2001) (95)
- Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritis. (1998) (95)
- A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation. (2015) (94)
- Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies (2005) (93)
- The state of complement in COVID-19 (2021) (93)
- Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign? (2014) (92)
- Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides. (2009) (89)
- The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome. (2008) (84)
- The role of complement in C3 glomerulopathy. (2015) (83)
- Effect of acetate, bicarbonate dialysis, and acetate-free biofiltration on nitric oxide synthesis: implications for dialysis hypotension. (1998) (82)
- Where next with atypical hemolytic uremic syndrome? (2007) (80)
- Thymic Dendritic Cells Express Inducible Nitric Oxide Synthase and Generate Nitric Oxide in Response to Self- and Alloantigens1 (2000) (77)
- Systemic and fetal–maternal nitric oxide synthesis in normal pregnancy and pre‐eclampsia (1996) (76)
- Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival (2017) (74)
- Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN. (2017) (71)
- In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS13 in thrombotic thrombocytopenic purpura (2006) (71)
- Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion. (2002) (71)
- Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome. (2007) (70)
- Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group (2009) (70)
- Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells. (2007) (68)
- Hemolytic uremic syndrome (2014) (68)
- Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy (2014) (67)
- In Kidney Transplant Patients, Alemtuzumab but Not Basiliximab/Low-Dose Rabbit Anti-Thymocyte Globulin Induces B Cell Depletion and Regeneration, Which Associates with a High Incidence of De Novo Donor-Specific Anti-HLA Antibody Development (2013) (65)
- Thrombotic thrombocytopenic purpura--then and now. (2006) (64)
- Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation. (2002) (63)
- Hemolytic uremic syndrome (1995) (63)
- Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury. (2008) (60)
- Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation (2013) (57)
- Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature. (2013) (57)
- Cardiovascular complications in atypical haemolytic uraemic syndrome (2014) (56)
- Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy. (2004) (56)
- Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report. (2005) (56)
- von Willebrand factor cleaving protease ( ADAMTS 13 ) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (2002) (56)
- Sequential monitoring of urine-soluble interleukin 2 receptor and interleukin 6 predicts acute rejection of human renal allografts before clinical or laboratory signs of renal dysfunction. (1997) (54)
- The Toll-IL-1R Member Tir8/SIGIRR Negatively Regulates Adaptive Immunity against Kidney Grafts1 (2009) (53)
- Genetic Atypical Hemolytic-Uremic Syndrome (2016) (52)
- Genetic analysis of the complement factor H related 5 gene in haemolytic uraemic syndrome. (2007) (51)
- Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator of microvascular injury. (1996) (50)
- PAF mediates neutrophil adhesion to thrombin or TNF-stimulated endothelial cells under shear stress. (1995) (49)
- Increased Fragmentation of von Willebrand Factor, Due to Abnormal Cleavage of the Subunit, Parallels Disease Activity in Recurrent Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura and Discloses Predisposition in Families (1999) (48)
- Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis. (2001) (48)
- Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group. (2020) (48)
- Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis (2017) (47)
- Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic Syndrome. (2015) (47)
- An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome. (2019) (47)
- Physiology and pathophysiology of nitric oxide in chronic renal disease. (1999) (46)
- Two Patients With History of STEC‐HUS, Posttransplant Recurrence and Complement Gene Mutations (2013) (45)
- Podocyte dysfunction in atypical haemolytic uraemic syndrome (2015) (44)
- Peripheral donor leukocytes prolong survival of rat renal allografts. (1999) (44)
- Dendritic Cells Genetically Engineered with Adenoviral Vector Encoding dnIKK2 Induce the Formation of Potent CD4+ T-Regulatory Cells (2005) (43)
- Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity (2013) (42)
- Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model. (1999) (41)
- Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes. (2010) (41)
- Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptides (1994) (39)
- Polymorphisms of EDNRB, ATG, and ACE genes in salt-sensitive hypertension. (2008) (38)
- Adeno-associated virus-mediated CTLA4Ig gene transfer protects MHC-mismatched renal allografts from chronic rejection. (2006) (38)
- ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established. (2003) (38)
- Nitric oxide/endothelin balance after nephron reduction. (1998) (37)
- Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury. (2012) (36)
- Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft. (2001) (36)
- Pretransplant Donor Peripheral Blood Mononuclear Cells Infusion Induces Transplantation Tolerance by Generating Regulatory T Cells (2005) (36)
- Protein load impairs factor H binding promoting complement-dependent dysfunction of proximal tubular cells. (2009) (36)
- L-arginine, the precursor of nitric oxide, abolishes the effect of estrogens on bleeding time in experimental uremia. (1991) (35)
- Genetics and genetic testing in hemolytic uremic syndrome/thrombotic thrombocytopenic purpura. (2010) (35)
- Lack of the Lectin-like Domain of Thrombomodulin Worsens Shiga Toxin-Associated Hemolytic Uremic Syndrome in Mice (2012) (34)
- Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (Campath-1H). (2006) (33)
- Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases. (2016) (32)
- Both Darbepoetin Alfa and Carbamylated Erythropoietin Prevent Kidney Graft Dysfunction Due to Ischemia/Reperfusion in Rats (2011) (31)
- ADAMTS13 Predicts Renal and Cardiovascular Events in Type 2 Diabetic Patients and Response to Therapy (2013) (30)
- Inherited thrombotic thrombocytopenic purpura (2009) (30)
- C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial. (2019) (29)
- DnIKK2-Transfected Dendritic Cells Induce a Novel Population of Inducible Nitric Oxide Synthase–Expressing CD4+CD25− Cells with Tolerogenic Properties (2007) (29)
- Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS (2019) (29)
- Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation (2010) (29)
- Nitric Oxide/L-Arginine in Uremia (1999) (29)
- Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome. (2017) (28)
- Erythropoietin enhances immunostimulatory properties of immature dendritic cells (2011) (28)
- Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management? (2005) (28)
- Translational Mini‐Review Series on Complement Factor H: Therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis (2007) (27)
- Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN (2018) (27)
- Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice (2021) (27)
- Complement Alternative Pathway Deficiency in Recipients Protects Kidney Allograft From Ischemia/Reperfusion Injury and Alloreactive T Cell Response (2017) (26)
- Treatment of Congenital Thrombotic Thrombocytopenic Purpura With Eculizumab. (2015) (26)
- Thymic microchimerism correlates with the outcome of tolerance-inducing protocols for solid organ transplantation. (2001) (26)
- New insights into circulating cell-endothelium interactions and their significance for glomerular pathophysiology. (1995) (25)
- 17β-Estradiol corrects hemostasis in uremic rats by limiting vascular expression of nitric oxide synthases (2000) (24)
- Prolonged cold ischemia accelerates cellular and humoral chronic rejection in a rat model of kidney allotransplantation (2012) (24)
- Rabbit anti‐rat thymocyte immunoglobulin preserves renal function during ischemia/reperfusion injury in rat kidney transplantation (2011) (23)
- Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy (2018) (23)
- Genetics of Immune-Mediated Glomerular Diseases: Focus on Complement. (2017) (22)
- Renal prostacyclin biosynthesis is reduced in children with hemolytic-uremic syndrome in the context of systemic platelet activation. (1992) (22)
- Urinary excretion of platelet-activating factor in haemolytic uraemic syndrome (1992) (22)
- Complement factor H and hemolytic uremic syndrome. (2001) (21)
- Platelet-activating factor mediates angiotensin II-induced proteinuria in isolated perfused rat kidney. (1997) (21)
- Urinary excretion of platelet activating factor in patients with immune-mediated glomerulonephritis. (1993) (21)
- Liver transplantation for aHUS: still needed in the eculizumab era? (2016) (21)
- C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19 (2021) (20)
- Nitric Oxide Synthetic Capacity in Relation to Dialysate Temperature (2004) (20)
- Increased fragmentation of von Willebrand factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predisposition in families. The Italian Registry of Familial and Recurrent HUS/TTP. (1999) (19)
- Structure-Function Studies of the Complement System (2002) (19)
- Discordant phenotype in monozygotic twins with renal coloboma syndrome and a PAX2 mutation (2012) (19)
- Methylprednisolone dosage effects on peripheral lymphocyte subpopulations and eicosanoid synthesis. (1992) (19)
- Non-Shiga toxin-associated hemolytic uremic syndrome (2006) (18)
- Non-muscle myosins and the podocyte (2012) (18)
- Klotho in acute kidney injury: biomarker, therapy, or a bit of both? (2010) (18)
- Thrombotic microangiopathy: What not to learn from a meta-analysis (2009) (17)
- Increased urinary excretion of platelet activating factor in mice with lupus nephritis. (1991) (17)
- α1-antitrypsin therapy in a case of thrombotic thrombocytopenic purpura (1995) (17)
- Thrombotic microangiopathies: from animal models to human disease and cure. (2011) (17)
- A Novel Antibody against Human Factor B that Blocks Formation of the C3bB Proconvertase and Inhibits Complement Activation in Disease Models (2014) (15)
- Single Strand Conformation Polymorphism (SSCP) as a quick and reliable method to genotype M235T polymorphism of angiotensinogen gene. (2002) (15)
- Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study (2021) (14)
- ACE inhibitors and AT1 receptor antagonists: is two better than one? (2002) (13)
- Renal metabolism and urinary excretion of platelet-activating factor in the rat. (1990) (13)
- ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal Impairment. (2015) (12)
- Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura (2010) (12)
- Nitric oxide synthesis and L-arginine in uremia. (1997) (12)
- Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Pro-Tolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation. (2019) (12)
- Kidney Transplantation in Patients With Atypical Hemolytic Uremic Syndrome: A Therapeutic Dilemma (or Not)? (2017) (11)
- Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022 (2022) (11)
- Embryonic Stem Cells, Derived Either after In Vitro Fertilization or Nuclear Transfer, Prolong Survival of Semiallogeneic Heart Transplants (2011) (11)
- CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis (2021) (11)
- Are HUS and TTP genetically determined? (1998) (11)
- Transplantation-Induced Ischemia-Reperfusion Injury Modulates Antigen Presentation by Donor Renal CD11c+F4/80+ Macrophages through IL-1R8 Regulation. (2020) (10)
- Propionyl-L-carnitine prevents early graft dysfunction in allogeneic rat kidney transplantation. (2008) (10)
- Reduced Nitric Oxide Bioavailability In a Baboon Model of Shiga Toxin Mediated Hemolytic Uremic Syndrome (HUS) (2005) (10)
- An Unanticipated Role for Survivin in Organ Transplant Damage (2014) (9)
- Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura (2016) (9)
- Complement Factor H Gene Abnormalities in Haemolytic Uraemic Syndrome: From Point Mutations to Hybrid Gene (2006) (9)
- More about Factor H Autoantibodies in Membranous Nephropathy. (2019) (8)
- The role of vasoactive molecules of endothelial origin in the pathophysiology of normal pregnancy and pregnancy-induced hypertension. (1996) (8)
- Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes (2019) (8)
- Disease : Improving Global Outcomes ” ( KDIGO ) Atypical hemolytic uremic syndrome and C 3 glomerulopathy : conclusions from a “ Kidney Controversies Conference (2017) (8)
- Identification of a novel gene--SSK1--in human endothelial cells exposed to shear stress. (1998) (8)
- Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment. (2021) (7)
- IgA nephropathy: a stem cell disease? (1999) (7)
- Posttransplant recurrence of atypical hemolytic uremic syndrome. (2012) (7)
- Autotaxin Inhibitor Protects from Chronic Allograft Injury in Rat Kidney Allotransplantation (2019) (7)
- Development of a mass spectrometric method to quantitate platelet activating factor in mouse urine. (1989) (7)
- Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant (2020) (7)
- In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS 13 in thrombotic thrombocytopenic purpura (2018) (6)
- Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase* (2016) (6)
- Evidence for a role of nitric oxide in hypertension and in renal disease in man. (1996) (6)
- Terminal complement effectors in atypical hemolytic uremic syndrome: C5a, C5b-9, or a bit of both? (2019) (6)
- Atypical hemolytic uremic syndrome associated with a factor B genetic variant and fluid-phase complement activation: an exception to the rule? (2020) (5)
- Effect of Seliciclib (CYC202, R-Roscovitine) on Lymphocyte Alloreactivity and Acute Kidney Allograft Rejection in Rat (2008) (5)
- Toward a B-cell signature of tolerance? (2010) (5)
- Familial and recurrent forms of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura. (2001) (5)
- Insights into the effects of complement factor H on the assembly and decay of the alternative pathway C3 proconvertase and C3 convertase. (2017) (5)
- Challenges in Understanding Acute Postinfectious Glomerulonephritis: Are Anti-Factor B Autoantibodies the Answer? (2020) (5)
- Erratum: 17β-estradiol corrects hemostasis in uremic rats by limiting vascular expression of nitric oxide synthases (American Journal of Physiology (October 2000) 279 (F626-F635)) (2001) (4)
- Thrombotic microangiopathy without renal involvement: two novel mutations in complement‐regulator genes (2016) (4)
- The complement alternative pathway and hemostasis (2022) (3)
- Disease of the Month Hemolytic Uremic Syndrome (2005) (3)
- Effect of a Novel Immunosuppressant, ST1959, on the Immune System and Renal Allograft Survival in Rats (2005) (3)
- Association of CFHR1 homozygous deletion with acute myelogenous leukemia in the European population (2016) (3)
- The case of complement inhibitors (2021) (3)
- Role of thymic- and graft-dependent mechanisms in tolerance induction to rat kidney transplant by donor PBMC infusion. (2007) (3)
- alpha 1-Antitrypsin therapy in a case of thrombotic thrombocytopenic purpura. (1995) (2)
- Prevalent FHR-1 mutant protein generated by gene conversion reveals crucial role of factor H polymorphisms in atypical Hemolytic Uremic Syndrome (aHUS) (2016) (2)
- presentation, response to treatment, and outcome Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical (2013) (2)
- Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis (2021) (2)
- Hemolytic Uremic Syndrome in an Infant with Primary Hyperoxaluria Type II: An Unreported Clinical Association (2019) (2)
- Fast Track Complement Factor H Mutation in Familial Thrombotic Thrombocytopenic Purpura with ADAMTS 13 Deficiency and Renal Involvement (2005) (2)
- Glomerular diseases in pregnancy: pragmatic recommendations for clinical management. (2022) (2)
- Nitric oxide as a mediator of hemodynamic disturbances in acute renal failure associated with sepsis (1998) (2)
- Mutations of factor H (HF) in familial Hemolytic Uremic Syndrome (HUS) / Thrombotic Thrombocytopenic Purpura (TTP) (2000) (2)
- Experimental pathology - 2 (2009) (2)
- Diverse Functional Implications of ADAMTS13 Gene Mutations in Patients with TTP and Congenital Deficiency. (2004) (2)
- 17beta-estradiol corrects hemostasis in uremic rats by limiting vascular expression of nitric oxide synthases. (2000) (2)
- 17 b -Estradiol corrects hemostasis in uremic rats by limiting vascular expression of nitric oxide synthases (2000) (1)
- The Toll-IL-1R Member Tir8 Modulates Post-Transplant Kidney Ischemia/reperfusion Injury By Inhibiting Resident F4/80+CX3CR1+ Cell Expansion.: Abstract# 2126 (2014) (1)
- Amnion epithelial cells are an effective source of factor H and prevent kidney complement deposition in factor H-deficient mice (2021) (1)
- Is local complement activation involved in renal damage in patients with atypical haemolytic uraemic syndrome? (2008) (1)
- Generation of Regulatory T Cells Semiallogeneic Heart Transplant through the Cells Prolongs the Survival of a Pretransplant Infusion of Mesenchymal Stem (2008) (1)
- A user-friendly method to study the effect of FH and impact of FB variants on C3bBb convertase and C3bB proconvertase formation (2012) (1)
- Defective glomerular [3H]lysoPAF metabolism in the autologous phase of rabbit nephrotoxic nephritis. (1993) (1)
- Interaction between multimeric VWF and complement: A fresh look to the pathophysiology of microvascular thrombosis (2017) (1)
- Chapter 26 – Thrombotic Microangiopathies (2008) (1)
- Therapeutic Corner Screening for Complement System Abnormalities in Patients with Atypical Hemolytic Uremic Syndrome (2007) (1)
- Prevalence of C3 mutations in primary membranoproliferative glomerulonephritis (2013) (1)
- In patients with atypical hemolytic uremic syndrome C5 activation causes loss of endothelial thromboresistance (2011) (1)
- Kidney Transplantation From a Donor With Acute Kidney Injury: An Unexpected Outcome (2014) (1)
- The factor H-aHUS mutation database and website: Update and integration of MCP and FI mutations with structural models (2007) (1)
- Residual Plasmatic Activity of ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura Correlates with Disease Phenotype (2011) (1)
- Unravelling the molecular mechanisms underlying complement dysregulation by nephritic factors in C3G and IC-MPGN (2018) (1)
- Report of the first World Transplant Congress. (2007) (1)
- Faculty Opinions recommendation of Organoids from Nephrotic Disease-Derived iPSCs Identify Impaired NEPHRIN Localization and Slit Diaphragm Formation in Kidney Podocytes. (2019) (0)
- A young girl with MPGN/HUS and a heterozygous CFH-mutation (2007) (0)
- Assay for c5b-9 deposition in complement-associated disorders (2017) (0)
- Chapter 14 Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura (2007) (0)
- Structure-Function-Disease map for the genetic abnormalities in the central complement component C3 (2011) (0)
- Donor Pbmc Induced Tolerance Is Associated With The Emergence Of Anergic T Cells From The Thymus Followed By Generation Of Regulatory T Cells In The Graft. (2004) (0)
- Contents Vol. 25, 1999 (1999) (0)
- Microvascular Thrombosis Exuberant C3a Formation That Triggers Complement by Shiga Toxin Promotes Alternative Pathway Activation of (2011) (0)
- The patient with haemolytic uraemic syndrome/thrombotic thrombocytopenic purpura (2015) (0)
- Pediatric liver transplantation for metabolic diseases (2002) (0)
- Induction of Tolerance in Allotransplantation (2007) (0)
- A study of 46 atypical HUS mutations reveals that C3 and factor H mutations mirror each other on protein surfaces, engaged in the C3b–FH complex (2012) (0)
- EFFECT OF A NOVEL IMMUNOSUPPRESSANT, ST1959, ON ALLOGENEIC IMMUNE RESPONSE AND RENAL ALLOGRAFT SURVIVAL IN RATS (2004) (0)
- Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity (2012) (0)
- TransplantsProlong Survival of Semiallogeneic Heart In Vitro Fertilization or Nuclear Transfer, Embryonic Stem Cells, Derived Either after (2011) (0)
- ERYTROPOIETIN PREVENTS ISCHEMIA-REPERFUSION INJURY IN A RAT MODEL OF KIDNEY TRANSPLANTATION (2006) (0)
- Brief report Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report thrombocytopenic (2005) (0)
- Dendritic Cells (dcs) Genetically Engineered To Block Nf-kb Pathway Induce The Formation Of Potent Type-1-like T Regulatory Cells (treg) (2004) (0)
- Oxide in Response to Self- and Alloantigens Nitric Oxide Synthase and Generate Nitric Thymic Dendritic Cells Express Inducible (2000) (0)
- Table 1. [Molecular Genetic Testing Used in Atypical Hemolytic-Uremic Syndrome]. (2016) (0)
- CAR 4Assembly and stability of C3 proconvertase and C3 convertase: Effect of CFH and C3NeF (2013) (0)
- POS-037 ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT FAVORS THROMBUS FORMATION ON MICROVASCULAR ENDOTHELIAL CELLS IN ACUTE HEMOLYTIC UREMIC SYNDROME INDUCED BY SHIGA-LIKE-TOXIN PRODUCING E.COLI (STEC-HUS) (2022) (0)
- C5a/C5aR interaction mediates complement activation and thrombosis on endothelial cells in atypical hemolytic uremic syndrome (aHUS) (2012) (0)
- Propionyl-L-carnitine prevents renal ischemia/reperfusion injury in a rat model of syngeneic kidney transplantation (2000) (0)
- Mele-NEJM-2011-appendix (2012) (0)
- Vasoactive and Inflammatory Substances (2004) (0)
- Table 2. [Selected CFB Pathogenic Variants]. (2016) (0)
- Role of the alternative pathway of complement in ischemia/reperfusion and chronic graft injury in a mouse model of kidney allograft (2012) (0)
- [Table, Molecular Genetics]. (2016) (0)
- Literature abstracts (2004) (0)
- Large spectrum of Factor B aHUS mutations functional consequences on the C3 convertase – From gain to lack of functional consequence (2012) (0)
- Rare but Relevant Kidney Disorders (2009) (0)
- Results for C3 and CFB genetic screening in atypical-HUS (2008) (0)
- aHUS-associated genetic complement abnormalities cause C3 deposition on endothelial cells: Protective effects of specific inhibitors of the alternative pathway of complement (2009) (0)
- Abstracts for IPNA Congress in Shanghai, China 2013 (2013) (0)
- 124Unravelling the pathophysiology of C3G/IC-MPGN and how to predict disease progression and orient therapies (2017) (0)
- CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome (2023) (0)
- Donor hematopoietic cells: central versus peripheral tolerance (2004) (0)
- Inhibition Of Interleukin-8 (il-8) Activity Prevents Renal Function Deterioration Due To Ischemia/reperfusion In Syngeneic And Allogeneic Rat Kidney Transplantation. (2004) (0)
- Development Donor-Specific Anti-HLA Antibody Associates with a High Incidence of De Novo Depletion and Regeneration , Which Anti-Thymocyte Globulin Induces B Cell but Not Basiliximab / Low-Dose Rabbit In Kidney Transplant Patients , Alemtuzumab (2013) (0)
- [Mechanisms of endothelial damage in thrombotic microangiopathy]. (2003) (0)
- POS-001 A NOVEL CFHR5 COPY NUMBER VARIATION ASSOCIATED WITH POST-PARTUM ATYPICAL HUS SUPERIMPOSED TO HELLP SYNDROME (2022) (0)
- A Putative Role of NO and Oxidant Injury in the Pathogenesis of Hemolytic Uremic Syndrome (1997) (0)
- Title Pages / Contents (1999) (0)
- Candidate genes screening in non-Stx-HUS (2007) (0)
- Database of complement gene variants: a comprehensive database providing insights on function, structure and allele frequency for genetic variants identified in complement-mediated diseases (2016) (0)
- Genetic rearrangements in CFH and CFH-Related genes in atypical Hemolytic Uremic Syndrome, C3 glomerulopathy and Immuno-Complex mediated MPGN (2017) (0)
- What determines the disease phenotype in factor H R1210C mutation carriers (2015) (0)
- CHAPTER 39 – Thrombotic microangiopathies (2012) (0)
- Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function (2017) (0)
- Renal transplantation - basic research (2009) (0)
- Complement factor H (CFH) haploinsufficiency causes spontaneous late onset glomerulonephritis (2011) (0)
- FP818Typical hemolytic uremic syndrome cohort screened for genetic complement abnormalities (2019) (0)
- Table 3. [Selected CFH Pathogenic Variants]. (2016) (0)
- Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival (2017) (0)
- A rapid and reliable method to detect homozygous CFHR1 deletion and its association with anti-factor H antibodies in atypical hemolytic uremic syndrome (2012) (0)
- A retrospective analysis on disease onset, number of episodes and final outcome in CFH mutated non-Stx-HUS patients (2007) (0)
- SP149ECULIZUMAB TREATMENT OF SHIGA TOXIN ESCHERICHIA COLI HEMOLYTIC UREMIC SYNDROME (2017) (0)
- Amnion epithelial cells are an effective source of factor H and prevent kidney complement deposition in factor H-deficient mice (2021) (0)
- An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome (2023) (0)
- MP032NEXT GENERATION GENE PANEL SCREENING IN STEROID-RESISTANT NEPHROTIC SYNDROME (2016) (0)
- Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 Glomerulopathy (2022) (0)
- SP004INHIBITION OF THE C5A RECEPTOR BY CCX168 MARKEDLY REDUCES THE THROMBOGENIC POTENTIAL OF SERUM FROM PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME (2015) (0)
- MDR1 POLYMORPHISMS INFLUENCES DAILY CYCLOSPORINE EXPOSURE IN STABLE KIDNEY TRANSPLANT RECIPIENTS. (2006) (0)
- This information is current as Activation in Disease Models Proconvertase and Inhibits Complement that Blocks Formation of the C3bB A Novel Antibody against Human Factor B (2014) (0)
- Subject Index Vol. 25, 1999 (1999) (0)
- syndrome syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP Membrane cofactor protein mutations in atypical hemolytic uremic (2013) (0)
- Every Fifteen Days Forever? (2022) (0)
- Complement (C) activation contributes to microvascular thrombosis in Shiga toxin-associated HUS (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Marina Noris?
Marina Noris is affiliated with the following schools:
